Researchers at the University of Pennsylvania have uncovered a fascinating link between a common anesthetic and cancer treatment. Their study suggests that lidocaine, a drug doctors frequently use to numb patients, may actually help kill certain cancer cells.
How Lidocaine Targets Cancer
For years, scientists noticed that lidocaine seemed to have anti-cancer properties. However, they did not understand the “how” or “why” until now. The team at Penn Medicine discovered that lidocaine activates a specific bitter taste receptor called T2R14.
While these receptors usually help us taste bitterness in our mouths, they also exist on the surface of many cancer cells. When lidocaine attaches to T2R14, it triggers a chain reaction that leads to apoptosis—the process of programmed cell death.
A New Mechanism for Cell Death
The study, published in Cell Reports, explains two unique ways lidocaine destroys these cells. First, the drug causes an overload of calcium in the cell’s mitochondria. This creates “reactive oxygen species” that damage the cell from the inside. Second, lidocaine inhibits the proteasome, a cellular machine that normally cleans up waste. When this machine stops working, the cell becomes overwhelmed and dies.
Future Clinical Applications
Because doctors already use lidocaine safely every day, it could become a seamless addition to cancer care. Researchers are particularly interested in head and neck squamous cell carcinomas (HNSCC). These cancers often express high levels of the T2R14 receptor, especially when associated with HPV.
Assistant Professor Ryan Carey, MD, noted that lidocaine is readily available and inexpensive. The team is now planning clinical trials to see if adding lidocaine to standard treatments can improve survival rates for patients with oral and throat cancers.
Improving Patient Outcomes
This research builds on a 2023 trial published in the Journal of Clinical Oncology, which found that breast cancer patients had better survival rates when they received lidocaine before surgery. By understanding the specific biological pathways involved, scientists can now refine these treatments to target tumors more effectively. While lidocaine is not a “cure,” it offers a promising new tool to give patients a significant edge in their fight against cancer.
References: Pandora, D. (November 23, 2023). Scientists Find Anesthetic Kills Cancer Cells Via Unique Mechanisms. Scientists Find Anesthetic Kills Cancer Cells Via Unique Mechanisms (newsweek.com)
#MedicalResearch #CulturalImpact
